|
JPS63107966A
(ja)
|
1986-05-22 |
1988-05-12 |
Fujisawa Pharmaceut Co Ltd |
ピリミジン誘導体
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
US5272158A
(en)
|
1991-10-29 |
1993-12-21 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5238950A
(en)
|
1991-12-17 |
1993-08-24 |
Schering Corporation |
Inhibitors of platelet-derived growth factor
|
|
GB9518953D0
(en)
|
1995-09-15 |
1995-11-15 |
Pfizer Ltd |
Pharmaceutical formulations
|
|
GB9711643D0
(en)
|
1997-06-05 |
1997-07-30 |
Janssen Pharmaceutica Nv |
Glass thermoplastic systems
|
|
AU1507199A
(en)
|
1997-12-15 |
1999-07-05 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel pyrimidine-5-carboxamide derivatives
|
|
AU2095099A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists
|
|
AU5107900A
(en)
|
1999-06-09 |
2000-12-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel heterocyclic carboxamide derivatives
|
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
|
WO2001043731A2
(en)
|
1999-12-16 |
2001-06-21 |
Alcon, Inc. |
Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
|
|
DE60118521T2
(de)
|
2000-01-07 |
2006-10-12 |
Universitaire Instelling Antwerpen |
Purin derivate, ihre herstellung und verwendung
|
|
KR20030016222A
(ko)
|
2000-02-14 |
2003-02-26 |
니뽄 다바코 산교 가부시키가이샤 |
수술후 스트레스 예방ㆍ치료제
|
|
JP2001302667A
(ja)
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
|
US7105667B2
(en)
|
2001-05-01 |
2006-09-12 |
Bristol-Myers Squibb Co. |
Fused heterocyclic compounds and use thereof
|
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
US20040235867A1
(en)
|
2001-07-24 |
2004-11-25 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
|
US20030158195A1
(en)
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
CA2495386C
(en)
|
2002-08-14 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
US7348335B2
(en)
|
2002-11-05 |
2008-03-25 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
EP1605946B1
(en)
|
2003-03-25 |
2008-05-28 |
Vertex Pharmaceuticals Incorporated |
Thiazoles useful as inhibitors of protein kinases
|
|
WO2004087698A2
(en)
|
2003-03-25 |
2004-10-14 |
Vertex Pharmaceuticals Incorporated |
Thiazoles useful as inhibitors of protein kinases
|
|
CA2518465A1
(en)
|
2003-03-25 |
2004-10-14 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
|
CN102358738A
(zh)
|
2003-07-30 |
2012-02-22 |
里格尔药品股份有限公司 |
2,4-嘧啶二胺化合物及其预防和治疗自体免疫疾病的用途
|
|
US7320992B2
(en)
|
2003-08-25 |
2008-01-22 |
Amgen Inc. |
Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
|
|
WO2005039564A1
(en)
|
2003-10-02 |
2005-05-06 |
Vertex Pharmaceuticals Incorporated |
Phthalimide compounds useful as protein kinase inhibitors
|
|
WO2005056524A2
(en)
|
2003-12-09 |
2005-06-23 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
|
US8057815B2
(en)
|
2004-04-19 |
2011-11-15 |
Portola Pharmaceuticals, Inc. |
Methods of treatment with Syk inhibitors
|
|
WO2006028833A1
(en)
|
2004-09-01 |
2006-03-16 |
Rigel Pharmaceuticals, Inc. |
Synthesis of 2,4-pyrimidinediamine compounds
|
|
JP5095409B2
(ja)
|
2004-11-24 |
2012-12-12 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
スピロ２，４−ピリミジンジアミン化合物およびその使用
|
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
EP1865775A1
(en)
|
2005-04-06 |
2007-12-19 |
Irm, Llc |
Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
|
|
AU2006237920A1
(en)
|
2005-04-19 |
2006-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Nitrogen-containing heterocyclic compound
|
|
WO2006129100A1
(en)
|
2005-06-03 |
2006-12-07 |
Glaxo Group Limited |
Novel compounds
|
|
WO2007002781A2
(en)
|
2005-06-28 |
2007-01-04 |
Bausch & Lomb Incorporated |
Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells
|
|
US20070185063A1
(en)
|
2005-08-23 |
2007-08-09 |
Idenix Pharmaceuticals, Inc. |
Seven-membered ring nucleosides
|
|
WO2007023382A2
(en)
|
2005-08-25 |
2007-03-01 |
Pfizer Inc. |
Pyrimidine amino pyrazole compounds, potent kinase inhibitors
|
|
WO2007053844A2
(en)
|
2005-10-31 |
2007-05-10 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for treating inflammatory disorders
|
|
JP5400388B2
(ja)
*
|
2005-12-15 |
2014-01-29 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
キナーゼインヒビターおよびその利用
|
|
TW201412738A
(zh)
|
2006-01-17 |
2014-04-01 |
Vertex Pharma |
適合作為傑納斯激酶（ｊａｎｕｓ ｋｉｎａｓｅ）抑制劑之氮雜吲哚
|
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
|
JPWO2008047831A1
(ja)
|
2006-10-17 |
2010-02-25 |
協和発酵キリン株式会社 |
Ｊａｋ阻害剤
|
|
US7981893B2
(en)
|
2006-10-19 |
2011-07-19 |
Signal Pharmaceuticals, Llc |
Heteroaryl compounds, compositions thereof, and methods of treatment therewith
|
|
WO2008057402A2
(en)
|
2006-11-02 |
2008-05-15 |
Cytovia, Inc. |
N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof
|
|
ES2380551T3
(es)
|
2006-11-21 |
2012-05-16 |
Rigel Pharmaceuticals, Inc. |
Sales de profármaco de compuestos de 2,4-pirimidindiamina y sus usos
|
|
CA2673965A1
(en)
|
2006-12-28 |
2008-07-10 |
Taisho Pharmaceutical Co., Ltd. |
Pyrazolopyrimidine compound
|
|
MX2009010207A
(es)
|
2007-03-23 |
2009-10-19 |
Schering Corp |
Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c.
|
|
NZ581817A
(en)
|
2007-06-03 |
2012-05-25 |
Univ Vanderbilt |
Benzamide mglur5 positive allosteric modulators and methods of making and using same
|
|
US7705004B2
(en)
|
2007-08-17 |
2010-04-27 |
Portola Pharmaceuticals, Inc. |
Protein kinase inhibitors
|
|
JP2009067729A
(ja)
|
2007-09-14 |
2009-04-02 |
Kyowa Hakko Kirin Co Ltd |
Ｈｓｐ９０ファミリー蛋白質阻害剤
|
|
CN101917999A
(zh)
|
2007-11-07 |
2010-12-15 |
弗尔德里克斯制药股份有限公司 |
蛋白质运输的调节
|
|
WO2009080638A2
(en)
|
2007-12-20 |
2009-07-02 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
|
NZ587039A
(en)
|
2008-02-13 |
2013-01-25 |
Gilead Connecticut Inc |
6-aryl-imidazo[1, 2-a]pyrazine derivatives, method of making, and method of use thereof
|
|
HRP20170050T1
(hr)
|
2008-02-22 |
2017-03-10 |
Rigel Pharmaceuticals, Inc. |
Uporaba 2,4-pirimidindiamina za liječenje ateroskleroze
|
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
|
JP5705720B2
(ja)
|
2008-04-16 |
2015-04-22 |
ポートラ ファーマシューティカルズ， インコーポレイテッド |
Ｓｙｋまたはｊａｋキナーゼ阻害剤としての２，６−ジアミノ−ピリミジン−５−イル−カルボキサミド
|
|
KR20100132550A
(ko)
|
2008-04-16 |
2010-12-17 |
포톨라 파마슈티컬스, 인코포레이티드 |
ｓｙｋ 또는 ＪＡＫ 키나제 억제제로서의 ２,６－디아미노-피리미딘－５－일－카르복스아미드
|
|
EA201100136A1
(ru)
|
2008-06-13 |
2011-08-30 |
Новартис Аг |
2,4'-бипиридинилы в качестве ингибиторов протеинкиназы d, применимые для лечения сердечной недостаточности и рака
|
|
WO2010015520A1
(de)
|
2008-08-05 |
2010-02-11 |
Boehringer Ingelheim International Gmbh |
Substituierte naphthyridine und ihre verwendung als arzneimittel
|
|
EP2313406B1
(de)
|
2008-08-05 |
2015-02-25 |
Boehringer Ingelheim International GmbH |
4-dimethylaminophenyl-substituierte napththyridine und ihre verwendung als arzneimittel
|
|
TWI453207B
(zh)
|
2008-09-08 |
2014-09-21 |
Signal Pharm Llc |
胺基三唑并吡啶，其組合物及使用其之治療方法
|
|
KR101743784B1
(ko)
|
2008-12-08 |
2017-06-05 |
질레드 코네티컷 인코포레이티드 |
이미다조피라진 ｓｙｋ 억제제
|
|
EP2443106A1
(en)
|
2009-06-18 |
2012-04-25 |
Cellzome Limited |
Heterocyclylaminopyrimidines as kinase inhibitors
|
|
WO2011075517A1
(en)
|
2009-12-17 |
2011-06-23 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
EP2512246B1
(en)
|
2009-12-17 |
2015-09-30 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
DK2516434T3
(en)
|
2009-12-23 |
2015-08-31 |
Takeda Pharmaceutical |
FUSED HETEROAROMATIC PYRROLIDINONS AS SICK INHIBITORS
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|